About: http://data.cimple.eu/news-article/e94e74e78f0c482248a2f4041ac07cccbaaaa378191552210e55e7be

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/e94e74e78f0c482248a2f4041ac07cccbaaaa378191552210e55e7be Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	European countries can keep using AstraZeneca's coronavirus vaccine during an investigation into cases of blood clots that prompted Denmark, Norway and Iceland to suspend jabs, the EU's drug regulator said on Thursday. There had been 30 cases of 'thromboembolic events' among five million people who've had the jab so far in Europe, the Amsterdam-based European Medicines Agency (EMA) said in a statement. "The position of EMA's safety committee... is that the vaccine's benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing," the EMA said. "There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine." Denmark, Norway and Iceland on Thursday temporarily suspended the use of AstraZeneca's Covid-19 vaccine over concerns about patients developing post-jab blood clots. The EMA said Denmark's decision was a "precautionary measure while a full investigation is ongoing into reports of blood clots in people who received the vaccine, including one case in Denmark where a person died". Of the 30 blood-clot cases across Europe, it said that "the number of thromboembolic events in vaccinated people is no higher than the number seen in the general population". The EMA covers the 27-nation EU plus Norway, Iceland and Lichtenstein. Italy's medicine regulator said Thursday it was banning a batch of the AstraZeneca/Oxford coronavirus vaccine over the issue. Austria announced it had suspended the use of a different AstraZeneca batch, after a 49-year-old nurse died of severe blood coagulation days after receiving the shot. Estonia, Latvia, Lithuania and Luxembourg have also suspended the use of the same batch as Austria. dk/jhe/har
schema:headline	AstraZeneca use can continue pending blood clot probe: EMA
schema:mentions	Latvia Liechtenstein Luxembourg Lithuania Estonia Coagulation European Medicines Agency Medication Iceland Austria Thrombus Jab University of Oxford Denmark Norway AstraZeneca Italy European Union Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Venous thrombosis
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-11 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	81 (xsd:integer)
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software